National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 1 of 1 Research Studies DisplayedMorrato EH, Parks J, Campagna EJ
Comparative effectiveness of injectable paliperidone palmitate versus oral atypical antipsychotics: early postmarketing evidence.
The researchers compared the likelihood of hospitalization and emergency department visits in Medicaid patients from the state of Missouri starting paliperidone palmitate versus oral atypical (also known as second-generation) antipsychotics. They found that paliperidone palmitate treatment resulted in a statistically significant 37 percent reduction in the adjusted likelihood of an all-cause emergency department visit. There was no statistically significant reduction in hospitalization.
AHRQ-funded; HS019464.
Citation: Morrato EH, Parks J, Campagna EJ .
Comparative effectiveness of injectable paliperidone palmitate versus oral atypical antipsychotics: early postmarketing evidence.
J Comp Eff Res 2015 Mar-Apr;4(2):89-99. doi: 10.2217/cer.14.50..
Keywords: Medication, Hospitalization, Behavioral Health, Emergency Department, Healthcare Utilization